JelikaLite to Launch Autism Therapy Device, Offers Early Access Waitlist JelikaLite has announced limited supply of the Cognilum device at its anticipated launch in 2024 and invites early sign-up in order to guarantee access as well as the exclusive waitlist discount. In addition, if you apply to...
Synchrony 2022 Roundtable Publication: The Role of Neuroinflammation in Behavioral Exacerbations in ASD We are glad to share that a summary paper has been published on Synchrony Symposia 2022 Roundtable: THE ROLE OF NEUROINFLAMMATION IN BEHAVIORAL EXACERBATIONS IN AUTISM SPECTRUM DISORDER. This...
The BRAIN Foundation Research Grants 2023 – Call for Applications 2023 Request for Proposals is now closed. We expect to open the next call for applications in Spring 2024. At The BRAIN Foundation, our primary focus is catalyzing basic and interdisciplinary translational research that leads...
Suramin for Autism Update: 2023 and Beyond Brought to you by the BRAIN FoundationIn partnership with PaxMedica About the event An exclusive interview with Howard Weisman, CEO of PaxMedica, on the latest developments and plans for FDA approval for suramin, a potential breakthrough treatment for...
Dedicated to our memory of Christopher Finnes and Nicholas D’Amora who inspired so many in their short but extraordinary lives Empowering Voices: A Community-Directed Panel Discussion on Epilepsy in Autism As an organization committed to serving individuals with autism, we understand the unique...
New Perspectives on Healing Chronic Diseases – a paper by Dr Naviaux In a paper published May 10, 2023 ‘Mitochondrial and metabolic features of salugenesis and the healing cycle’ Dr Robert Naviaux, professor of Medicine, Pediatrics and Pathology at UC San Diego whose work has been supported...
The BRAIN Foundation at Paxmedica’s NASDAQ Closing Bell Event It was a great honor for The BRAIN Foundation to join the PaxMedica team as they rang the NASDAQ Closing Bell last week. PaxMedica is is a clinical-stage biopharmaceutical company spearheading the development of innovative...
Synchrony 2022 Roundtable Publication: Epilepsy and Seizures in Autism We are happy to share that a summary paper has been published on Synchrony Symposia 2022 SEIZURES IN AUTISM Roundtable, one of the four discussions that took place during the event that focused on some of the most difficult and...
Synchrony 2023 – Call for Abstracts Synchrony 2023 Call for Abstracts is now closed. Sign up to our mailing list to be notified of future opportunities and events What is Synchrony? Synchrony is the first and only international symposium on translational research in autism that brings...
The BRAIN Foundation Industry Seed Investment in Jelikalite The BRAIN Foundation is happy to announce our seed investment in JelikaLite for a total raise of $760,000 along with our co-investors. JelikaLite is a medical technology company with a focus on neurological health in pediatric population...
Synchrony 2022 Meeting Report: Catalyzing Research and Treatments The paper summarizing our latest Synchrony Symposia was published in March 2023 edition of the Journal of Personalized Medicine. Synchrony 2022 brought together both basic and clinical sciences from both academia and industry to...